Baseline observations from the POSSIBLE EU® study: characteristics of postmenopausal women receiving bone loss medications.
Freemantle N, Cooper C, Roux C, Díez-Pérez A, Guillemin F, Jonsson B, Ortolani S, Pfeilschifter J, Horne R, Kakad S, Shepherd S, Möller G, Marciniak A, Martinez L.
Freemantle N, et al. Among authors: pfeilschifter j.
Arch Osteoporos. 2010 Dec;5(1-2):61-72. doi: 10.1007/s11657-010-0035-7. Epub 2010 Feb 27.
Arch Osteoporos. 2010.
PMID: 21258637
Free PMC article.